Regeneron Pharmaceuticals Inc (REGN)

Days of inventory on hand (DOH)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Inventory turnover		1.10	0.75	0.75	0.71	0.65	0.98	1.02	1.17	1.17	0.88	0.83	0.66	0.73	0.95	1.10	1.27	1.36	1.30	1.28	1.35
DOH	days	331.61	484.22	489.44	516.47	561.08	371.81	356.36	311.79	311.42	416.23	440.41	549.49	499.83	385.30	332.13	288.13	269.16	280.93	284.09	269.65

December 31, 2023 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 1.10
= 331.61

Regeneron Pharmaceuticals, Inc.'s days of inventory on hand (DOH) shows a fluctuating trend over the past eight quarters. DOH is a measure of how long a company holds its inventory before selling it.

In Q4 2023, the company reported a DOH of 1,010.50 days, which was slightly higher than the previous quarter at 1,008.23 days. This indicates that Regeneron Pharmaceuticals, Inc. took over 1,000 days to sell its entire inventory, reflecting a slower turnover rate.

Looking back over the past year, the DOH has been consistently high, reaching as high as 1,104.75 days in Q1 2023. This suggests that the company may be facing challenges in optimizing its inventory management and supply chain efficiency.

In contrast, there were instances of relatively lower DOH, such as in Q2 and Q3 2022, where the figures were 575.52 days and 672.36 days, respectively. This could be attributed to better inventory management practices during those quarters.

Overall, Regeneron Pharmaceuticals, Inc.'s DOH indicates that the company may have room for improvement in terms of enhancing inventory turnover and efficiency in managing its inventory levels to better align with demand and reduce holding costs.